Lupin, JMC Projects and Fortis Healthcare among top stocks to track

The markets are likely to move in a narrow range on Tuesday amid lack of major domestic and global cues. Most Asian markets are shut on account of New Year. That apart, market participants are expected to react to core sector numbers, which was released post market hours on Monday.

Here's a look at the top stocks that are likely to remain in focus today -

Lupin: The drug maker Lupin said it has received approval from the US health regulator for Clobazam Oral Suspension, used to treat seizures associated with Lennox-Gastaut Syndrome. The drug is indicated for treatment of